Results 281 to 290 of about 3,236,788 (346)

The Path to a Match for Interventional Cardiology Fellowship: A Major SCAI Initiative. [PDF]

J Soc Cardiovasc Angiogr Interv
Drachman DE, Addo T, Applegate RJ, Bartel RC, Bortnick AE, Dea FM, Helmy T, Henry TD, Khalif A, Kirtane AJ, Levy M, Lim MJ, Mahmud E, Mihatov N, Parikh SA, Porter L, Prasad A, Rao SV, Razzouk L, Shah S, Shroff A, Tamis-Holland JE, Velagapudi P, Welt FG, Abbott JD.   +24 more
europepmc   +1 more source

A Technical and Cognitive Skills Evaluation of Performance in Interventional Cardiology Procedures Using Medical Simulation

, 2010
Rebecca S. Lipner, John C. Messenger, Roberta Kangilaski, Donald S. Baim, David R. Holmes, David O. Williams, Spencer B. King   +6 more
openalex   +1 more source

Assessment of the Occupational Radiation Exposure of Anesthesia Staff in Interventional Cardiology. [PDF]

Risk Manag Healthc Policy
Shbeer A.
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Interventional cardiology: a 2023 recap and what to expect in 2024. [PDF]

AsiaIntervention
Alasnag M, Alameer M.
europepmc   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Advancements in artificial intelligence-driven techniques for interventional cardiology. [PDF]

Cardiol J
Rudnicka Z, Pręgowska A, Glądys K, Perkins M, Proniewska K.   +4 more
europepmc   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Estimating brain and eye lens dose for the cardiologist in interventional cardiology-are the dose levels of concern? [PDF]

Br J Radiol
Hulthén M, Tsapaki V, Karambatsakidou A.   +2 more
europepmc   +1 more source